{"retracted":false,"update":{"timestamp":1413331200000,"doi":"10.1016/j.ejps.2014.06.005","type":"err"},"doi":"10.1016/j.ejps.2010.07.003","journal":"European Journal of Pharmaceutical Sciences","publisher":"Elsevier BV","title":"Corrigendum to “Properties and effects of a novel liquid crystal nanoparticle formulation of docetaxel in a prostate cancer mouse model” [Eur. J. Pharm. Sci. 41 (2) (2010) 369–375]"}
